April 21-27 | Los Angeles

2018 AAN Annual Meeting

Advancing Neurology, Advancing You

Early Registration Deadline: March 29, 2018

Hotel Deadline: March 2, 2018

70th Anniversary Celebration Ticket Information

Browse Plenary Sessions

Hear from more than 40 leading researchers presenting the latest advances in neuroscience at the meeting's seven plenary sessions—one each day beginning Saturday evening.

Hot Topics Plenary Session

Saturday, April 21 
4:15 p.m.-5:30 p.m. 

Features translational research related to clinical issues of importance. Four outstanding physician-scientists will provide summaries of their recent research findings and describe the clinical implications of the results.

Presidential Plenary Session

Sunday, April 22
9:15 a.m.-12:00 p.m.

Features the AAN's premier lecture awards for clinically relevant research and a presentation by a leading lecturer. Top researchers speak on some of the most significant findings in neurology in 2018.

Natalia S. Rost, MD, FAAN
Chair, AAN Science Committee










Presidential Lecture
California Dreaming: BRAIN and Precision Medicine in 2018
Francis S. Collins, MD, PhD
National Institutes of Health, Bethesda, MD









Sidney Carter Award in Child Neurology
Spinal Muscular Atrophy Is a Treatable Neurodegenerative Disease
Richard S. Finkel, MD
Nemours Children's Hospital, Orlando, FL








George C. Cotzias Lecture
How Early-life Experiences Sculpt Your Brain: From Molecules to Circuits
Tallie Z. Baram, MD, PhD
University of California-Irvine, Irvine, CA








Robert Wartenberg Lecture
Neuro-Oncology: How Cancer and the Nervous System Interact
Lisa M. DeAngelis, MD
Memorial Sloan Kettering Cancer Center, New York, NY

Contemporary Clinical Issues Plenary Session

Monday, April 23
9:15 a.m.-11:30 a.m.

Highlights issues most critical to practicing neurologists, including abstracts related to new therapeutic developments, clinical applications of basic and translational research, and innovative technical developments. Commentary and discussion follow each presentation.

Clinical Trials Plenary Session

Tuesday, April 24
9:15 a.m.-11:30 a.m.

This session covers important clinical topics identified from other society meetings that affect patient care. The latest updates within several clinical trials conducted over the course of the last year will be presented.

Frontiers in Neuroscience Plenary Session

Wednesday, April 25
9:15 a.m.-11:30 a.m.

This plenary session features basic and translational research related to clinical issues of importance. Six outstanding physician-scientists provide summaries of their recent research findings and describe the clinical implications of the results.

Paul M. George, MD, PhD, MSE
Member, Science Committee









The Dynamics of the Unconscious Brain Under General Anesthesia
Emery N. Brown, MD, PhD
Massachusetts Institute of Technology
Cambridge, MA








Does Connectomics Make Sense?
Jeff Lichtman, MD, PhD
Harvard University
Cambridge, MA









Biology of Bedtime: Understanding Circadian Rhythms and Sleep
Amita Sehgal, PhD
University of Pennsylvania
Haverford, PA








Combining Patient-Derived Cell and Animal Models to Uncover Epilepsy Mechanisms and Precision Therapies
Jack M. Parent, MD
University of Michigan
Ann Arbor, MI








BigBrain: A High Resolution 3D Digital Human Brain Atlas
Alan Evans, PhD
McGill University
Montreal, QC, Canada








Pediatric MS: A Unique Window into Environmental and Genetic Risk Factors for MS
Emmanuelle Waubant, MD, FAAN
UCSF MS Center
San Francisco, CA

Controversies in Neurology Plenary Session

Thursday, April 26
9:15 a.m.-11:30 a.m. 

This session features experts discussing the most current and controversial issues in neuroscience. It is set up as a debate format in which two speakers argue one side of a single topic, followed by a rebuttal. This plenary session will feature audience response technology to create an interactive attendee experience. Please look for more details during this session at the Annual Meeting.

Aleksandar Videnovic, MD, MSc, FAAN
Member, Science Committee

Amy R. Brooks-Kayal, MD, FAAN
Member, Science Committee

Should We Use Biomarkers Alone For Diagnosis of Alzheimer’s?

Michael W. Weiner, MD
San Francisco, CA

Maria Glymour, ScD, MS
University of California,
San Francisco, CA

Would You Let Your Child Play Contact Sports?

Jack W. Tsao, MD, DPhil, FAAN
Memphis, TN

Christopher Giza, MD
UCLA, Dept of Neurosurgery,
Los Angeles, CA

Should the Neurologist Be Primarily Responsible for Taking Care of Patients with Functional Disorders?

David L. Perez, MD
Massachusetts General Hospital,
Boston, MA

Andrea Leigh Haller, MD
Fort Wayne Neurological Center,
Fort Wayne, IN

Neurology Year in Review: Emerging Therapies Plenary Session

Friday, April 27
9:15 a.m.-11:30 a.m.

This session will feature six speakers, each focusing on the latest research that has happened in the last year within a specific subspecialty topic.

Antonio M. P. Omuro, MD
Member, Science Committee

A Year in Review of Neuromuscular Diseases: Making Treatments Great Again
Ericka P. Simpson, MD, FAAN
Methodist Hospital
Houston, TX

Pediatric Epilepsy
Kelly G. Knupp, MD
Children’s Hospital Colorado
Aurora, CO

Neuro-oncology Year in Review: Progress, Breakthroughs, and Future Directions
Antonio M. P. Omuro, MD
University of Miami Miller School of Medicine,
Miami, FL

Liana Apostolova, MD, FAAN
Indiana University School of Medicine
Indianapolis, IN

Headache Medicine 2018: Year in Review
Matthew S. Robbins, MD, FAAN
Montefiore Headache Center
Bronx, NY

Finally, Some Closure on PFO Closure
Steven R. Messé, MD, FAAN, FAHA
Hospital of the University of Pennsylvania
Philadelphia, PA